Iovance's Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced MelanomaGlobeNewsWire • 08/18/25
IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for AmtagviZacks Investment Research • 08/08/25
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/07/25
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025GlobeNewsWire • 08/07/25
This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy?The Motley Fool • 07/29/25
This Healthcare Stock Just Hit a 52-Week Low -- but Wall Street Sees 380% UpsideThe Motley Fool • 07/21/25
Iovance: I'm Switching From Sell To Buy Despite Likely Approval For Rival DrugSeeking Alpha • 07/18/25
IOVANCE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Iovance Biotherapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 07/15/25
Levi & Korsinsky Reminds Iovance Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025 – IOVAGlobeNewsWire • 07/14/25
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance BiotherapeuticsBusiness Wire • 07/14/25
IOVA FINAL DEADLINE ALERT: Hagens Berman Alerts Iovance (IOVA) Investors to Today's Lead Plaintiff Deadline in Securities Class ActionGlobeNewsWire • 07/14/25
FINAL IOVANCE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Iovance Biotheapeutics, Inc. (IOVA) to Inquire About Their Rights in Class Action LawsuitGlobeNewsWire • 07/14/25
IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELVPRNewsWire • 07/14/25
Lost Money on Iovance Biotherapeutics, Inc.(IOVA)? Join Class Action Suit Seeking Recovery - Contact The Gross Law FirmPRNewsWire • 07/14/25
Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced MelanomaGlobeNewsWire • 07/14/25